← Back to Search

Cervical Cancer Prevention Program for Muslim Women

N/A

Waitlist Available

Research Sponsored by Mark Dignan, PhD

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial will develop and evaluate an intervention program to help Muslim American women learn about and accept cervical cancer prevention.

Eligible Conditions

Human Papillomavirus
Cervical Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of women who undergo cervical cancer screening.

Secondary outcome measures

Number of women enrolled

Other outcome measures

Number of women that attend the education session

Trial Design

1Treatment groups

Experimental Treatment

Group I: The single-arm trial with a pre- and post-test designExperimental Treatment1 Intervention

The Intervention Arm in the Promise Women Project evaluates a specific educational intervention program for Muslim women to promote cervical cancer prevention. It involves a one-time, 90-minute culturally and religiously tailored educational session with 20 participants. The session covers perceived risks of Human Papilloma Virus (HPV) infection, cervical cancer, and benefits of early screening and vaccination. Pre- and post-intervention surveys measure changes in participants' knowledge. This experimental arm assesses the intervention's effects on knowledge and acceptance of cervical cancer prevention.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Promise women project (Promote Cervical Cancer Prevention Methods Among Muslim Women in Virginia )

2023

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mark Dignan, PhDLead Sponsor

1 Previous Clinical Trials

669 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,933,123 Total Patients Enrolled

Virginia Commonwealth UniversityOTHER

697 Previous Clinical Trials

22,884,966 Total Patients Enrolled

Media Library

The single-arm trial with a pre- and post-test design Clinical Trial Eligibility Overview. Trial Name: NCT05862844 — N/A

Human Papillomavirus Research Study Groups: The single-arm trial with a pre- and post-test design

Human Papillomavirus Clinical Trial 2023: The single-arm trial with a pre- and post-test design Highlights & Side Effects. Trial Name: NCT05862844 — N/A

The single-arm trial with a pre- and post-test design 2023 Treatment Timeline for Medical Study. Trial Name: NCT05862844 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings in this research project?

"This clinical trial, posted on June 1st 2023 and updated the 8th of May 2023 is not presently accepting any patient participations. However, there are 480 other trials actively recruiting individuals for their research at this time"

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Promise Women Project

Mark Dignan, PhD 2023. "Promise Women Project". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05862844.